Recombinant human PIGT protein; Source: E. coli derived, PGEX-4T; Tag: GST; Domain: 230-578 aa of BC015022
Conjugate
Unconjugated
Applications
Application Notes
WB: 1:500-1:1000 IP: 0.5-4.0 μg for 1.0-3.0 mg of total protein lysate IHC: 1:100-1:500 IF/ICC: 1:50-1:500
General Notes
This product (Catalog No. DPABH-18076) is a rabbit-derived polyclonal antibody raised against human PIGT, targeting the amino acid region 230–578 of the protein. This antibody exhibits cross-reactivity with Human PIGT from mouse. It has been affinity purified by Protein A. PIGT is a subunit of the glycosylphosphatidylinositol transamidase complex that catalyzes the attachment of proteins to GPI-anchors. GPI-anchors are glycolipids found on membrane of diverse cells that help proteins anchoring to the cell surface. Mutations of PIGT have been linked to developmental disorders including multiple congenital anomalies-hypotonia-seizures syndrome-3. Multiple isoforms of PIGT exist due to the alternative splicing, with the predicted MWs ranging from 42 kDa to 66 kDa. DPABH-18076 is suitable for use in Western blot (WB) (1:500–1:1,000), IP (0.5-4.0 μg for 1.0-3.0 mg of total protein lysate), IHC (1:100–1:500), IF/ICC (1:50–1:500) applications. DPABH-18076 is supplied as a liquid formulation in PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. For long-term storage, keep at −20 °C. For short-term use, store at 2–8 °C. Avoid repeated freeze–thaw cycles to maintain antibody integrity and performance.
Target
Alternative Names
CGI-06; GPI transamidase component PIG-T; NDAP; Phosphatidylinositol-glycan biosynthesis class T protein; PSEC0163
My Review for Rabbit Anti-Human PIGT (a.a. 230-578) Polyclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.